Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity; Recurrent Mucoepidermoid Carcinoma of the Oral Cavity; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Stage 0 Hypopharyngeal Cancer; Stage 0 Laryngeal Cancer; Stage 0 Lip and Oral Cavity Cancer; Stage I Adenoid Cystic Carcinoma of the Oral Cavity; Stage I Mucoepidermoid Carcinoma of the Oral Cavity; Stage I Squamous Cell Carcinoma of the Hypopharynx; Stage I Squamous Cell Carcinoma of the Larynx; Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage I Verrucous Carcinoma of the Larynx; Stage I Verrucous Carcinoma of the Oral Cavity; Stage II Adenoid Cystic Carcinoma of the Oral Cavity; Stage II Mucoepidermoid Carcinoma of the Oral Cavity; Stage II Squamous Cell Carcinoma of the Hypopharynx; Stage II Squamous Cell Carcinoma of the Larynx; Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II Verrucous Carcinoma of the Larynx; Stage II Verrucous Carcinoma of the Oral Cavity; Stage III Adenoid Cystic Carcinoma of the Oral Cavity; Stage III Mucoepidermoid Carcinoma of the Oral Cavity; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Verrucous Carcinoma of the Larynx; Stage III Verrucous Carcinoma of the Oral Cavity; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity; Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity; Stage IVA Squamous Cell Carcinoma of the Larynx; Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVA Verrucous Carcinoma of the Larynx; Stage IVA Verrucous Carcinoma of the Oral Cavity; Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity; Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity; Stage IVB Squamous Cell Carcinoma of the Larynx; Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVB Verrucous Carcinoma of the Larynx; Stage IVB Verrucous Carcinoma of the Oral Cavity; Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity; Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity; Stage IVC Squamous Cell Carcinoma of the Larynx; Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVC Verrucous Carcinoma of the Larynx; Stage IVC Verrucous Carcinoma of the Oral Cavity; Tongue Cancer
Interventions: Procedure: transoral robotic surgery; Procedure: quality of life assessment
Sponsor: Enver Ozer
Recruiting - verified October 2016
http://ift.tt/2edl455
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
▼
2016
(13807)
- ► Δεκεμβρίου (700)
-
▼
Οκτωβρίου
(650)
-
▼
Οκτ 21
(50)
- Antigen-Specific Immune Modulation Targets mTORC1 ...
- Accumulation of CD11c+CD163+ Adipose Tissue Macrop...
- G-CSF-Induced Suppressor IL-10+ Neutrophils Promot...
- Humoral Immunity Provides Resident Intestinal Eosi...
- Circulating Soluble IL-6R but Not ADAM17 Activatio...
- JAK2 Disease-Risk Variants Are Gain of Function an...
- Dok-1 and Dok-2 Regulate the Formation of Memory C...
- Antigen Targeting to Human HLA Class II Molecules ...
- Inositol-Triphosphate 3-Kinase C Mediates Inflamma...
- MK2/3 Are Pivotal for IL-33-Induced and Mast Cell-...
- Upregulation of IFN-Inducible and Damage-Response ...
- A Tetravalent Formulation Based on Recombinant Nuc...
- Antibody Binding to CD4 Induces Rac GTPase Activat...
- HIF-2{alpha} in Resting Macrophages Tempers Mitoch...
- Antigen-Specific Development of Mucosal Foxp3+ROR{...
- Von Willebrand Factor Interacts with Surface-Bound...
- CD4-Transgenic Zebrafish Reveal Tissue-Resident Th...
- High Doses of GM-CSF Inhibit Antibody Responses in...
- Chemotaxis and Immunoregulatory Function of Cardia...
- Papillary Thyroid Carcinoma Cervical Lymph Node Me...
- Papillary Thyroid Carcinoma Cervical Lymph Node Me...
- Heterogeneity of CD8 + tumor-infiltrating lymphocy...
- Threshold dose distribution and eliciting dose of ...
- Resolution of Pulsatile Tinnitus after Venous Sinu...
- Erratum to: Remifentanil for labor analgesia: a co...
- Rare case of type I hypersensitivity reaction to s...
- Two tunnels for one peritoneal dialysis catheter: ...
- Rare cause of massive haemoptysis in pulmonary tub...
- Mediastinal osteosarcoma metastasis causing right ...
- Rare case of T-cell lymphoma presenting as acute m...
- Total recovery of optic nerve sheath meningioma
- Infant bald patch: ultrasonographic diagnosis of a...
- The efficacy and safety of apremilast, etanercept,...
- Factors associated with combined hand and foot ecz...
- Update HNO
- TPC vs PF as Induction Chemotherapy Combined With ...
- Transoral Robotic Surgery in Treating Patients Wit...
- Epidermale Barrierestörung bei Dermatosen
- Flüchtlingswelle als Herausforderung für europäisc...
- Squamous cell carcinoma of the penis successfully ...
- In response to “Asbestos exposure and laryngeal ca...
- Applicant characteristics associated with successf...
- Systematic review for surgical treatment of adult ...
- Cataract Surgery with a New Fluidics Control Phaco...
- Modified anastomotic technique for thoracolaparosc...
- Perfusion of the gastric conduit during esophagectomy
- Effect of neoadjuvant chemoradiotherapy on periope...
- Definitive chemoradiation for locoregional recurre...
- Quality of life and fear of cancer recurrence afte...
- Neurofibroma with naevus of Ota
-
▼
Οκτ 21
(50)
- ► Σεπτεμβρίου (600)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου